IDiyas

For the Inventor, By the Inventor

Bray Maidenhead, United Kingdom

Graham Sturton

USPTO Granted Patents = 13

Average Co-Inventor Count = 9.8

ph-index = 6

Forward Citations = 94(Granted Patents)


Location History:

  • Slough, GB (1987)
  • Bray, GB (1997)
  • Maidenhead, GB (2001 - 2005)
  • Bray Maidenhead, GB (1996 - 2006)
  • Maidenhead, Berkshire, GB (2006)

Company Filing History:

goldMedal12 out of 12,157 
 
Bayer Aktiengesellschaft
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 1987-2006

Loading Chart...
13 patents (USPTO):Explore Patents
1. 7115602 - Heterocycles 3 (2006-10-03),
2. 7074790 - 5-ethylimidarotriazones (2006-07-11),
3. 6900194 - Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases (2005-05-31),
4. 6677372 - N-(3-benzofuranyl)urea-derivatives (2004-01-13),
5. 6610687 - Benzofuranylsulfonates (2003-08-26),
6. 6399657 - N-(3-benzofuranyl) urea-derivatives (2002-06-04),
7. 6169092 - 3-Ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes (2001-01-02),
8. 5922740 - Heterocyclylcarbonyl substituted benzofuranyl-ureas (1999-07-13),
9. 5691359 - Heterocyclylcarbonyl substituted benzofuranyl- and (1997-11-25),
10. 5622989 - Amino-benzofuryl-and thienyl-derivatives (1997-04-22),
11. 5565488 - Oxalylamino-benzofuran- and benzothienyl-derivatives (1996-10-15),
12. 5504213 - Benzofuranyl-and-thiophenyl-alkanecarboxyclic acid derivatives (1996-04-02),
13. 4698344 - 1-Heteroaryl-4-aryl-pyrazolin-5-ones for use as medicaments (1987-10-06),

Title: **Innovative Contributions of Graham Sturton in Medicinal Chemistry**

Introduction

Graham Sturton is a prominent inventor based in Bray Maidenhead, GB, known for his significant contributions to medicinal chemistry. With an impressive portfolio of 13 patents to his name, Sturton focuses on developing innovative compounds aimed at treating inflammatory processes and immune diseases.

Latest Patents

Among Sturton's latest inventions are two notable patents that demonstrate his expertise in creating novel pharmaceutical compounds. The first patent, titled "Heterocycles 3," pertains to the formulation of 7-(4-tert butyl-cyclohexyl)-imidazotriazinones. This invention encompasses processes for their preparation and application in medicaments, particularly targeting the treatment and prophylaxis of inflammatory processes and immune diseases. The second patent, "5-ethylimidarotriazones," introduces novel 5-ethyl-imidazotriazinones, along with their preparation processes and usage in similar medical applications.

Career Highlights

Sturton has built a notable career within the pharmaceutical industry, including a significant tenure at Bayer Aktiengesellschaft, a leading global enterprise in healthcare and agriculture. His work in such esteemed organizations has allowed him to refine his skills and contribute to the development of cutting-edge medicinal solutions.

Collaborations

Throughout his career, Sturton has collaborated with esteemed professionals, enhancing his research through teamwork. Notable colleagues include Mary F Fitzgerald and Mazen Es-Sayed, with whom he has shared knowledge and expertise in the field.

Conclusion

Graham Sturton's dedication to innovation in the pharmaceutical realm continues to make a substantial impact on healthcare solutions. His latest patents reflect a commitment to addressing critical health issues through inventive chemical processes. As he moves forward in his career, his contributions will undoubtedly lead to further advancements in medicinal chemistry and improved therapeutic options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…